newsfilter
← Latest News
Business Wire·

Dexcom Appoints Glenn Boehnlein to Board of Directors

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein is a highly accomplished